Glapp — Smart GLP-1 Tracker
By Glapp
Glapp is a specialized health-tracking app for GLP-1 medication users on iOS and Android, centered on shot-timing and supply inventory.
The App DNA
What makes this app unique?
The app removes the cognitive load of tracking complex medication cycles, replacing manual logs with automated level-curve projections.
For Individuals prescribed GLP-1 medications like Mounjaro, Ozempic, or Wegovy seeking to track their treatment, side effects, and weight loss progress.
What does it look like?
Key features
Visualizes estimated drug levels in the body to help users predict hunger and side-effect shifts.
Logs vials and pens with automatic dose deduction and expiration alerts.
Searchable database of clinical trials and research.
How much does it cost?
Freemium model utilizing in-app purchases to monetize a specialized health-tracking tool.
Velocity
Active developmentUX improvementsperformanceShow more...
Glapp maintains an active development pace, shipping three releases over the last 12 days across iOS and Android. The development team is currently focused on refining core health-tracking features, specifically improving dose management and data visualization. This consistent update frequency indicates a stable, active product lifecycle aimed at iterative UX improvements. The cadence remains steady, with the latest version providing functional enhancements to existing tracking tools.
Who built it?
User Sentiment
What do users think recently?
The recent review mood reads excited. Users appreciate detailed medication level tracking and shot phase visualizations help users understand their body and side effects and intuitive interface design makes logging daily medication and supply levels feel simple and efficient for users, but report paywalling previously free features after a recent update creates significant friction for long-term loyal users.
How are ratings & reviews evolving?
What users say, by theme
- Detailed medication level tracking and shot phase visualizations help users understand their body and side effects
- Intuitive interface design makes logging daily medication and supply levels feel simple and efficient for users
- Integration with health platforms allows users to sync their weight and health data without manual entry
- Paywalling previously free features after a recent update creates significant friction for long-term loyal users
50 of 50 recent reviews analyzed · high confidence · Excited overall
Read the full review analysisUnlock 2 more frustration themes and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Glapp — Smart GLP-1 Tracker
How's the Health & Fitness market?
Glapp occupies a specialized niche within the Health & Fitness category, maintaining a 4.75 rating across 1,231 total ratings. The recent transition to subscription-gating core features has created a significant sentiment gap between the app's utility and its perceived value.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Glapp — Smart GLP-1 Tracker
Where is it heading?
The GLP-1 tracking space is consolidating, and Glapp's recent shift to a more aggressive subscription model is testing user loyalty during a period of technical instability. If the team does not address the performance regressions immediately, the current rating advantage will erode, leaving the app vulnerable to leaner, more stable competitors.
- Performance regressions in the latest update (freezing, loading failures) erode the daily habit, which compounds the rating drag already visible on Android.
- Subscription-gating previously free features creates significant friction, causing loyal users to compare costs unfavorably against competing apps.
The SWOT
- Medication-level visualization creates a defensible barrier against generic weight-loss trackers
- Automated supply inventory tracking reduces user friction in medication management
- Adding body measurement and progress photo tracking would address the top user request
- Refining the subscription value proposition could mitigate churn among long-term users
Next best moves
Audit and patch performance regressions in the latest update because freezing during shot entry is a critical churn risk → restore the daily habit
+ 1 more prioritized moveThe counter-intuitive read
The subscription-gating of core features is not just a monetization failure…
Read the full takeSince the last report: Glapp has transitioned its strategic focus toward mitigating churn caused by subscription-gating and performance regressions. The product roadmap now prioritizes stability and requested progress-tracking features over content expansion to address user dissatisfaction.
Bottom line
Restoring stability after recent performance regressions is the immediate priority to prevent churn. Once the core experience is reliable, pivoting to include requested progress-tracking features will better justify the current subscription pricing.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated